Paroxetine 7.5 mg Provided a Rapid and Durable Reduction in Vasomotor Symptoms Associated With Menopause Following Treatment Initiation

被引：0
|
作者：
Portman, David [1 ]
Pinkerton, JoAnn V. [2 ]
Bhaskar, Sailaja [3 ]
Lippman, Joel [3 ]
机构：
[1] Columbus Ctr Womens Hlth Res, Columbus, OH USA
[2] Univ Virginia, Div Midlife Hlth, Charlottesville, VA USA
[3] Noven Pharmaceut Inc, New York, NY USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2014年 / 21卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
S-20
引用
收藏
页码：1333 / 1333
页数：1
相关论文
共 47 条
  • [1] Efficacy of Paroxetine (7.5 mg) in the treatment of menopause-associated vasomotor symptoms
    Belardo, Maria A.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (12): : 1459 - 1459
  • [2] Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause
    Pinkerton, JoAnn V.
    Joffe, Hadine
    Kazempour, Kazem
    Mekonnen, Hana
    Bhaskar, Sailaja
    Lippman, Joel
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (01): : 50 - 58
  • [3] Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause
    Portman, David J.
    Kaunitz, Andrew M.
    Kazempour, Kazem
    Mekonnen, Hana
    Bhaskar, Sailaja
    Lippman, Joel
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (10): : 1082 - 1090
  • [4] Safety Profile of Paroxetine 7.5 mg in Women With Moderate-to-Severe Vasomotor Symptoms
    Simon, James A.
    Portman, David J.
    Kazempour, Kazem
    Mekonnen, Hana
    Bhaskar, Sailaja
    Lippman, Joel
    [J]. OBSTETRICS AND GYNECOLOGY, 2014, 123 : 132S - 133S
  • [5] Fezolinetant in the treatment of vasomotor symptoms associated with menopause
    Depypere, Herman
    Lademacher, Christopher
    Siddiqui, Emad
    Fraser, Graeme L.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (07) : 681 - 694
  • [6] Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
    Pinkerton, JoAnn V.
    Simon, James A.
    Joffe, Hadine
    Maki, Pauline M.
    Nappi, Rossella E.
    Panay, Nick
    Soares, Claudio N.
    Thurston, Rebecca C.
    Caetano, Cecilia
    Haberland, Claudia
    Mashhadi, Nazanin Haseli
    Krahn, Ulrike
    Mellinger, Uwe
    Parke, Susanne
    Seitz, Christian
    Zuurman, Lineke
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [7] Paroxetine 7.5 mg to Treat Moderate to Severe Vasomotor Symptoms Associated With Menopause: Safety Profile From 3 Multicenter, Double-blind, Randomized, Controlled Trials
    Portman, David J.
    Simon, James A.
    Kazempour, Kazem
    Bhaskar, Sailaja
    Mekonnen, Hana
    Lippman, Joel
    [J]. JOURNAL OF WOMENS HEALTH, 2014, 23 (04) : 10 - 10
  • [8] Nonestrogen treatment modalities for vasomotor symptoms associated with menopause
    Fugate, SE
    Church, CO
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : 1482 - 1499
  • [9] Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials
    Simon, James A.
    Portman, David J.
    Kaunitz, Andrew M.
    Mekonnen, Hana
    Kazempour, Kazem
    Bhaskar, Sailaja
    Lippman, Joel
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (10): : 1027 - 1035
  • [10] Paroxetine 7.5 mg Reduces Daily Frequency and Severity of Vasomotor Symptoms (VMS) Associated With Menopause: Results From 2 Multicenter, Randomized, Double-blind, Controlled Phase 3 Studies
    Kazempour, Kazem
    Bhaskar, Sailaja
    Mekonnen, Hana
    Lippman, Joel
    Kaunitz, Andrew M.
    Pinkerton, Joann
    [J]. JOURNAL OF WOMENS HEALTH, 2014, 23 (04) : 17 - 17
12345